Showing results (331-340 of 351) with videos related to
Sort By:
Pageof 36
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 26, 2011
Efficacy and safety in sitagliptin therapy for diabetes complicated by chronic liver disease caused by hepatitis C virusYasuji Arase, Fumitaka Suzuki, Mariko Kobayashi, et al.Journal of Medical Virology|January 21, 2010
Virus clearance reduces bone fracture in postmenopausal women with osteoporosis and chronic liver disease caused by hepatitis C virusYasuji Arase, Fumitaka Suzuki, Yoshiyuki Suzuki, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 17, 2020
Effects of alcohol consumption on multiple hepatocarcinogenesis in patients with fatty liver diseaseYorinari Ochiai, Yusuke Kawamura, Masahiro Kobayashi, et al.Liver Cancer|June 24, 2026
Nivolumab plus Ipilimumab versus Lenvatinib or Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: CheckMate 9DW Japanese Subgroup AnalysisMasatoshi Kudo, Atsushi Hiraoka, Kazushi Numata, et al.Oncology|November 18, 2020
Potential and Clinical Significance of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Evaluating Liver Cancer Response to Lenvatinib TreatmentDaiki Yamashige, Yusuke Kawamura, Masahiro Kobayashi, et al.Liver Cancer|January 14, 2021
Lenvatinib-Transarterial Chemoembolization Sequential Therapy as an Effective Treatment at Progression during Lenvatinib Therapy for Advanced Hepatocellular CarcinomaYusuke Kawamura, Masahiro Kobayashi, Junichi Shindoh, et al.Journal of Gastroenterology|October 15, 2020
PNPLA3 and HLA-DQB1 polymorphisms are associated with hepatocellular carcinoma after hepatitis C virus eradicationDaiki Miki, Tomoyuki Akita, Akemi Kurisu, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 20, 2011
Difference in malignancies of chronic liver disease due to non-alcoholic fatty liver disease or hepatitis C in Japanese elderly patientsYasuji Arase, Mariko Kobayashi, Fumitaka Suzuki, et al.Internal Medicine (Tokyo, Japan)|May 18, 2011
The development of chronic kidney disease in Japanese patients with non-alcoholic fatty liver diseaseYasuji Arase, Fumitaka Suzuki, Mariko Kobayashi, et al.Plos One|December 31, 2013
HLA-DQB1*03 confers susceptibility to chronic hepatitis C in Japanese: a genome-wide association studyDaiki Miki, Hidenori Ochi, Atsushi Takahashi, et al.Pageof 36